Skip to main content

Advertisement

Log in

Characterizing the frequency of modifiable histological changes observed on surveillance biopsies in pediatric kidney allograft recipients

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Rejection is responsible for just under 50% of graft loss in the pediatric kidney transplant population. Early identification and treatment of allograft injury, specifically modifiable pathologies such as subclinical rejection (SCR), calcineurin inhibitor toxicity, and BK virus nephropathy, may improve allograft survival. Protocol surveillance biopsy (SB) currently offers the earliest opportunity for targeted interventions.

Methods

This is a single-center retrospective review of 215 kidney SBs obtained from 2008 to 2016 in 97 pediatric kidney transplant recipients. SBs were obtained at 6, 12, and 24 months post-transplantation. Frequency of abnormal histologic findings, estimated glomerular filtration rate at time of SB, and SB-related complications were recorded. Data were analyzed to investigate possible time trends and the presence of demographic or clinical associations with abnormal histologic findings.

Results

Potentially modifiable histologic findings were seen in 38.1% of all SBs. SCR was found with increasing frequency across all time points with an estimated 49% increase in the odds of a SCR finding per additional 6 months post-transplantation (aOR 1.49, 95% CI 1.06–2.09, p = 0.022). Among follow-up biopsies in patients who underwent treatment for SCR, 50% had no SCR and 18.8% showed histologic improvement. The complication rate associated with SB was 1.9% (4/215 SBs) and consisted of only minor complications.

Conclusions

SBs are safe and offer the opportunity to identify and treat modifiable histologic changes in the pediatric kidney transplant population. The performance of SBs for up to 2 years after transplantation can have meaningful clinical impact.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. National Data - OPTN. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/#. Accessed 24 Oct 2019

  2. Karcz M, Kusztal M, Boratyńska M, Klinger M (2018) Very long-term survival of the transplanted kidney-characteristics of recipients. Transplant Proc 50:1730–1732. https://doi.org/10.1016/j.transproceed.2018.02.114

    Article  CAS  PubMed  Google Scholar 

  3. Sert I, Yavascan Ö, Tugmen C, Orhan DK, Kilinc S, Dogan SM, Bal A, Kebabci E, Alparslan C, Karaca C, Aksu N (2013) A retrospective analysis of long-term graft survival in 61 pediatric renal transplant recipients: a single-center experience. Ann Transplant 18:497–504. https://doi.org/10.12659/AOT.889117

    Article  CAS  PubMed  Google Scholar 

  4. Naderi G, Latif A, Karimi S, Tabassomi F, Esfahani ST (2017) The long-term outcome of pediatric kidney transplantation in Iran: results of a 25-year single-center cohort study. Int J Organ Transplant Med 8:85–96

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Hebert SA, Swinford RD, Hall DR, Au JK, Bynon JS (2017) Special considerations in pediatric kidney transplantation. Adv Chronic Kidney Dis 24:398–404. https://doi.org/10.1053/j.ackd.2017.09.009

    Article  PubMed  Google Scholar 

  6. Graves RC, Fine RN (2016) Kidney retransplantation in children following rejection and recurrent disease. Pediatr Nephrol 31:2235–2247

    Article  Google Scholar 

  7. Cihan Y, Kanzelmeyer N, Drube J, Kreuzer M, Lerch C, Hennies I, Froede K, Verboom M, Ahlenstiel-Grunow T, Pape L (2017) Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation. Pediatr Nephrol 32:2133–2142. https://doi.org/10.1007/s00467-017-3725-1

    Article  PubMed  Google Scholar 

  8. Moreso F, Ibernon M, Gomà M, Carrera M, Fulladosa X, Hueso M, Gil-Vernet S, Cruzado JM, Torras J, Grinyó SD (2006) Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 6:747–752. https://doi.org/10.1111/j.1600-6143.2005.01230.x

    Article  CAS  PubMed  Google Scholar 

  9. Kanzelmeyer NK, Ahlenstiel T, Drube J, Froede K, Kreuzer M, Broecker V, Ehrich JHH, Melk A, Pape L (2010) Protocol biopsy-driven interventions after pediatric renal transplantation. Pediatr Transplant 14:1012–1018. https://doi.org/10.1111/j.1399-3046.2010.01399.x

    Article  CAS  PubMed  Google Scholar 

  10. Seikku P, Krogerus L, Jalanko H, Holmberg C (2005) Better renal function with enhanced immunosuppression and protocol biopsies after kidney transplantation in children. Pediatr Transplant 9:754–762

    Article  CAS  Google Scholar 

  11. Gordillo R, Munshi R, Monroe EJ, Shivaram GM, Smith JM (2019) Benefits and risks of protocol biopsies in pediatric renal transplantation. Pediatr Nephrol 34:593–598. https://doi.org/10.1007/s00467-018-3959-6

    Article  PubMed  Google Scholar 

  12. Rose EM, Kennedy SE, Mackie FE (2016) Surveillance biopsies after paediatric kidney transplantation: a review. Pediatr Transplant 20:748–755. https://doi.org/10.1111/petr.12733

    Article  PubMed  Google Scholar 

  13. Zotta F, Guzzo I, Morolli F, Diomedi-Camassei F, Strologo LD (2018) Protocol biopsies in pediatric renal transplantation: a precious tool for clinical management. Pediatr Nephrol 33:2167–2175. https://doi.org/10.1007/s00467-018-4007-2

    Article  PubMed  Google Scholar 

  14. Rush D, Arlen D, Boucher A, Busque S, Cockfield SM, Girardin C, Knoll G, Lachance JG, Landsberg D, Shapiro J, Shoker A, Yilmaz Y (2007) Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. Am J Transplant 7:2538–2545. https://doi.org/10.1111/j.1600-6143.2007.01979.x

    Article  CAS  PubMed  Google Scholar 

  15. Mehta R, Sood P, Hariharan S (2016) Subclinical rejection in renal transplantation: reappraised. Transplantation 100:1610–1618. https://doi.org/10.1097/TP.0000000000001163

    Article  PubMed  Google Scholar 

  16. Henderson LK, Nankivell BJ, Chapman JR (2011) Surveillance protocol kidney transplant biopsies: their evolving role in clinical practice. Am J Transplant 11:1570–1575. https://doi.org/10.1111/j.1600-6143.2011.03677.x

    Article  CAS  PubMed  Google Scholar 

  17. Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MCR, David DSR, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB III, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M (2014) Banff 2013 Meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14:272–283. https://doi.org/10.1111/ajt.12590

    Article  CAS  PubMed  Google Scholar 

  18. Kambham N, Nagarajan S, Shah S, Li L, Salvatierra O, Sarwal MM (2007) A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. Clin J Am Soc Nephrol 2:135–142. https://doi.org/10.2215/CJN.01320406

    Article  PubMed  Google Scholar 

  19. Nickeleit V, Singh HK, Randhawa P, Drachenberg CB, Bhatnagar R, Bracamonte E, Chang A, Chon WJ, Dadhania D, Davis VG, Hopfer H, Mihatsch MJ, Papadimitriou JC, Schaub S, Stokes MB, Tungekar MF, Seshan SV (2018) The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: morphologic definitions and clinical correlations. J Am Soc Nephrol 29:680–693. https://doi.org/10.1681/ASN.2017050477

    Article  PubMed  Google Scholar 

  20. Mian AN, Schwartz GJ (2017) Measurement and estimation of glomerular filtration rate in children. Adv Chronic Kidney Dis 24:348–356. https://doi.org/10.1053/j.ackd.2017.09.011

    Article  PubMed  PubMed Central  Google Scholar 

  21. de Souza V, Cochat P, Rabilloud M, Selistre L, Wagner M, Hadj-Aissa A, Dolomanova O, Ranchin B, Iwaz J, Dubourg L (2015) Accuracy of different equations in estimating GFR in pediatric kidney transplant recipients. Clin J Am Soc Nephrol 10:463–470. https://doi.org/10.2215/CJN.06300614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Selistre L, De Souza V, Cochat P, Antonello ICF, Hadj-Aissa A, Ranchin B, Dolomanova O, Varennes A, Beyerle F, Bachetta J, Dubourg L (2012) GFR estimation in adolescents and young adults. J Am Soc Nephrol 23:989–996. https://doi.org/10.1681/ASN.2011070705

    Article  CAS  PubMed  Google Scholar 

  23. Selistre L, Rabilloud M, Cochat P, de Souza V, Iwaz J, Lemoine S, Beyerle F, Poli-de-Figueiredo CE, Dubourg L (2016) Comparison of the Schwartz and CKD-EPI equations for estimating glomerular filtration rate in children, adolescents, and adults: a retrospective cross-sectional study. PLoS Med 13:e1001979. https://doi.org/10.1371/journal.pmed.1001979

    Article  PubMed  PubMed Central  Google Scholar 

  24. Alkandari O, Hebert D, Langlois V, Robinson LA, Parekh RS (2017) Validation of serum creatinine-based formulae in pediatric renal transplant recipients. Pediatr Res 82:1000–1006. https://doi.org/10.1038/pr.2017.209

    Article  CAS  PubMed  Google Scholar 

  25. Birk PE (2012) Surveillance biopsies in children post-kidney transplant. Pediatr Nephrol 27:753–760. https://doi.org/10.1007/s00467-011-1969-8

    Article  PubMed  Google Scholar 

  26. Dharnidharka VR, Vyas N, Gaut JP, Walther L, Hmiel SP (2018) The utility of surveillance biopsies in pediatric kidney transplantation. Pediatr Nephrol 33:889–895. https://doi.org/10.1007/s00467-017-3864-4

    Article  PubMed  Google Scholar 

  27. Birk PE, Blydt-Hansen TD, Dart AB, Kaita LM, Proulx C, Taylor G (2007) Low incidence of adverse events in outpatient pediatric renal allograft biopsies. Pediatr Transplant 11:196–200

    Article  Google Scholar 

  28. Nazario M, Nicoara O, Becton L, Self S, Hill J, Mack E, Evans M, Twombley K (2018) Safety and utility of surveillance biopsies in pediatric kidney transplant patients. Pediatr Transplant 22:e13178. https://doi.org/10.1111/petr.13178

    Article  CAS  PubMed  Google Scholar 

  29. Rush DN, Henry SF, Jeffery JR, Schroeder TJ, Gough J (1994) Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 57:208–211

    Article  CAS  Google Scholar 

  30. Rush D (2006) Protocol transplant biopsies: an underutilized tool in kidney transplantation. Clin J Am Soc Nephrol 1:138–143. https://doi.org/10.2215/CJN.00390705

    Article  PubMed  Google Scholar 

  31. Foster BJ, Dahhou M, Zhang X, Platt RW, Samuel SM, Hanley JA (2011) Association between age and graft failure rates in young kidney transplant recipients. Transplantation 92:1237. https://doi.org/10.1097/TP.0b013e31823411d7

    Article  PubMed  Google Scholar 

  32. Tanabe T (2014) The value of long-term protocol biopsies after kidney transplantation. Nephrology (Carlton) 19(Suppl 3):2–5. https://doi.org/10.1111/nep.12253

    Article  Google Scholar 

  33. Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD (2005) Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 5:2464–2472. https://doi.org/10.1111/j.1600-6143.2005.01050.x

    Article  PubMed  Google Scholar 

  34. Stegall MD, Park WD, Larson TS, Gloor JM, Cornell LD, Sethi S, Dean PG, Prieto M, Amer H, Textor S, Schwab T, Cosio FG (2011) The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant 11:698–707. https://doi.org/10.1111/j.1600-6143.2010.03312.x

    Article  CAS  PubMed  Google Scholar 

  35. Hergesell O, Felten H, Andrassy K, Kühn K, Ritz E (1998) Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant 13:975–977. https://doi.org/10.1093/ndt/13.4.975

    Article  CAS  PubMed  Google Scholar 

  36. Hassler J, Tanriover B, Ariyamutu V, Burguete D, Hendricks AR, Torrealba JR (2019) 2013 Banff criteria for acute antibody-mediated rejection are superior to 2007 Banff criteria in the diagnosis and assessment of renal allograft outcomes. Transplant Proc 51:1791–1795. https://doi.org/10.1016/j.transproceed.2019.04.060

    Article  PubMed  Google Scholar 

  37. Chua A, Cramer C, Moudgil A, Martz K, Smith J, Blydt-Hansen T, Neu A, Dharnidharka VR (2019) Kidney transplant practice patterns and outcome benchmarks over 30 years: the 2018 report of the NAPRTCS. Pediatr Transplant 23:e13597. https://doi.org/10.1111/petr.13597

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bradley A. Warady.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Odum, J.D., Kats, A., VanSickle, J.S. et al. Characterizing the frequency of modifiable histological changes observed on surveillance biopsies in pediatric kidney allograft recipients. Pediatr Nephrol 35, 2173–2182 (2020). https://doi.org/10.1007/s00467-020-04624-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-020-04624-1

Keywords

Navigation